Khan Bilal Arshad
SEC Form 4 insider trading activity
Khan Bilal Arshad has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 11, 2026.
On the most recent filing, Khan Bilal Arshad is listed as Director at SpyGlass Pharma, Inc. Inside the rolling window, Khan Bilal Arshad reported 1 open-market purchase totaling $2.2M in SGP and no open-market sales.
Companies traded
Other insiders at SGP
Insider Buying
$2.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Khan Bilal Arshad made?
Khan Bilal Arshad has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Khan Bilal Arshad trade?
Khan Bilal Arshad has filed SEC Form 4 disclosures for 1 company, including SGP.
When was Khan Bilal Arshad's most recent SEC Form 4 filing?
Khan Bilal Arshad's most recent SEC Form 4 filing on Tracefour is dated Feb 11, 2026.
What is Khan Bilal Arshad's total buy and sell value in the current window?
Inside the rolling retention window, Khan Bilal Arshad bought $2.2M and sold $0 based on SEC Form 4 filings.
What was Khan Bilal Arshad's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 135,000 SGP shares on 2026-02-09, worth $2.2M, per SEC Form 4 filings.